# Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control

Study · id `cardio:ct-nct01669928` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01669928](<https://clinicaltrials.gov/study/NCT01669928>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01669928

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

## Technical summary

Registry record NCT01669928. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2015-07 (actual). Results posted on 2021-03-08.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT01669928, source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)
- Started: 2012-04 (actual) (ClinicalTrials.gov record NCT01669928, source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)
- Primary completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01669928, source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01669928, source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)
- Results first posted: 2021-03-08 (ClinicalTrials.gov record NCT01669928, source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)
- Countries: Greece; United Kingdom (ClinicalTrials.gov record NCT01669928, source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01669928-2021-03-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
- Acronym: HARMONY
- Condition: Hypertension
- Intervention (Drug): Anti-hypertensive Medication -
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER
- Collaborator: Aristotle University Of Thessaloniki
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Imperial College London (`cardio:org-imperial-college-london`)
- Registry lists this organization as a collaborator: Aristotle University Of Thessaloniki (`cardio:org-aristotle-university-of-thessaloniki`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood Pressure (`cardio:pubmed-30354703`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c1fd8688c44bc6a23581f7ed8e3cf1713eaf5d9f34b45e2925aaab802772956c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
